Literature DB >> 24386554

Histological experimental study on the effect of stem cell therapy on adriamycin induced chemobrain.

Maha Baligh Zickri1, Dalia Hussein Abd El Aziz2, Hala Gabr Metwally3.   

Abstract

BACKGROUND AND OBJECTIVES: Negative consequences of chemotherapy on brain function were suggested and were addressed in animal models as the clinical phenomenon of chemobrain .It was postulated that adriamycin (ADR) induce changes in behaviour and in brain morphology. Human umbilical cord mesenchymal stem cells (HUCMSCs) could be induced to differentiate into neuron-like cells .The present study aimed at investigating the possible therapeutic effect of HUCMSC therapy on adriamycin induced chemobrain in rat. METHODS AND
RESULTS: Twenty five female albino rats were divided into control group, ADR group where rats were given single intraperitoneal (IP) injection of 5 mg/kg ADR. The rats were sacrificed two and four weeks following confirmation of brain damage. In stem cell therapy group, rats were injected with HUCMSCs following confirmation of brain damage and sacrificed two and four weeks after therapy. Brain sections were exposed to histological, histochemical, immunohistochemical and morphometric studies. In ADR group, multiple shrunken neurons exhibiting dark nuclei and surrounded by vacuoles were seen .In response to SC therapy ,multiple normal pyramidal nerve cells were noted. The area of shrunken nerve cells exhibiting dark nuclei, Prussion blue and CD105 positive cells were significantly different in ADR group in comparison to SC therapy group.
CONCLUSIONS: ADR induced progressive duration dependant cerebral degenerative changes. These changes were ameliorated following cord blood human mesenchymal stem cell therapy. A reciprocal relation was recorded between the extent of regeneration and the existence of undifferentiated mesenchymal stem cells.

Entities:  

Keywords:  Adriamycin; Chemobrain; Cord blood; Mesenchymal stem cells

Year:  2013        PMID: 24386554      PMCID: PMC3878203          DOI: 10.15283/ijsc.2013.6.2.104

Source DB:  PubMed          Journal:  Int J Stem Cells        ISSN: 2005-3606            Impact factor:   2.500


  21 in total

Review 1.  Mediation and moderation of treatment effects in randomised controlled trials of complex interventions.

Authors:  Richard Emsley; Graham Dunn; Ian R White
Journal:  Stat Methods Med Res       Date:  2009-07-16       Impact factor: 3.021

2.  Recombinant human interleukin-1 receptor antagonist protects mice against acute doxorubicin-induced cardiotoxicity.

Authors:  Jinzhou Zhu; Jing Zhang; Di Xiang; Zhonghui Zhang; Lin Zhang; Mingyuan Wu; Shunying Zhu; Ruiyan Zhang; Wei Han
Journal:  Eur J Pharmacol       Date:  2010-06-30       Impact factor: 4.432

Review 3.  Chemo brain (chemo fog) as a potential side effect of doxorubicin administration: role of cytokine-induced, oxidative/nitrosative stress in cognitive dysfunction.

Authors:  Christopher D Aluise; Rukhsana Sultana; Jitbangjong Tangpong; Mary Vore; Daret St Clair; Jeffrey A Moscow; D Allan Butterfield
Journal:  Adv Exp Med Biol       Date:  2010       Impact factor: 2.622

4.  The CD40-CD154 co-stimulation pathway mediates innate immune injury in adriamycin nephrosis.

Authors:  Vincent W S Lee; Xiaohong Qin; Yiping Wang; Guoping Zheng; Ya Wang; Ying Wang; Jon Ince; Thian K Tan; Lukas K Kairaitis; Stephen I Alexander; David C H Harris
Journal:  Nephrol Dial Transplant       Date:  2009-11-04       Impact factor: 5.992

Review 5.  The potential for cell-based therapy in perinatal brain injuries.

Authors:  Andre W Phillips; Michael V Johnston; Ali Fatemi
Journal:  Transl Stroke Res       Date:  2013-04       Impact factor: 6.829

6.  Doxorubicin increases the susceptibility of brain mitochondria to Ca(2+)-induced permeability transition and oxidative damage.

Authors:  Susana Cardoso; Renato X Santos; Cristina Carvalho; Sónia Correia; Gonçalo C Pereira; Susana S Pereira; Paulo J Oliveira; Maria S Santos; Teresa Proença; Paula I Moreira
Journal:  Free Radic Biol Med       Date:  2008-08-14       Impact factor: 7.376

7.  The impact of cancer therapy on cognition in the elderly.

Authors:  Victoria Mandilaras; Doreen Wan-Chow-Wah; Johanne Monette; Francine Gaba; Michèle Monette; Linda Alfonso
Journal:  Front Pharmacol       Date:  2013-04-19       Impact factor: 5.810

8.  Apoferritin modified magnetic particles as doxorubicin carriers for anticancer drug delivery.

Authors:  Iva Blazkova; Hoai Viet Nguyen; Simona Dostalova; Pavel Kopel; Maja Stanisavljevic; Marketa Vaculovicova; Marie Stiborova; Tomas Eckschlager; Rene Kizek; Vojtech Adam
Journal:  Int J Mol Sci       Date:  2013-06-27       Impact factor: 5.923

Review 9.  Opening up the window into "chemobrain": a neuroimaging review.

Authors:  Carole S Scherling; Andra Smith
Journal:  Sensors (Basel)       Date:  2013-03-06       Impact factor: 3.576

10.  Isolation of mesenchymal stem cells from equine umbilical cord blood.

Authors:  Thomas G Koch; Tammy Heerkens; Preben D Thomsen; Dean H Betts
Journal:  BMC Biotechnol       Date:  2007-05-30       Impact factor: 2.563

View more
  2 in total

1.  Stem Cell Therapies for the Resolution of Radiation Injury to the Brain.

Authors:  Sarah M Smith; Charles L Limoli
Journal:  Curr Stem Cell Rep       Date:  2017-10-11

2.  Psychobiotic Effects of Multi-Strain Probiotics Originated from Thai Fermented Foods in a Rat Model.

Authors:  Vijitra Luang-In; Teeraporn Katisart; Ampa Konsue; Sutisa Nudmamud-Thanoi; Arjan Narbad; Worachot Saengha; Eakapol Wangkahart; Supaporn Pumriw; Wannee Samappito; Nyuk Ling Ma
Journal:  Food Sci Anim Resour       Date:  2020-11-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.